Clinical Trial Update: Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and pharmacokinetics of GSK573719 alone and in combination with GW642444(VI) in healthy subjects and those with severe ren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK573719
• GSK573719/GW642444(VI)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED